A monoclonal antibody (MAb) that blocks most echoviruses (EVs) from in
fecting rhabdomyosarcoma (RD) cells has been isolated. By using the CE
LICS cloning method (T. Ward, P. A. Pipkin, N. A. Clarkson, D. M. Ston
e, P. D. Minor, and J. W. Almond, EMBO J. 13:5070-5074, 1994), the lig
and for this antibody has been identified as beta 2-microglobulin (bet
a 2m), the 12-kDa protein that associates with class I heavy chains to
form class I HLA complexes, A commercial MAb (MAb 1350) against beta
2m was also found to block EV7 infection without affecting binding to
its receptor, DAF, or replication of EV7 viral RNA inside cells, Entry
of EV7 into cells was reduced by only 30% by antibody and cytochalasi
n D, an inhibitor of endocytosis mediated by caveolae and clathrin-coa
ted pits, but was not significantly reduced by sodium azide, The block
to virus entry by cytochalasin D was additive to the block induced by
antibody. We suggest that EV7 rapidly enters into a multicomponent re
ceptor complex prior to entry into cells and that this initial entry e
vent requires beta 2m or class I HLA for infection to proceed.